Markt oder Branche auswählen:
Chart-Typ:
Zeitraum:
| Reliance Industries Reports Higher Q3 FY26 Profit On Revenue Growth | MUMBAI (dpa-AFX) - Reliance Industries Limited (RELIANCE.NS) on Friday reported a steady financial performance for the third quarter ended December 31, 2025, supported by growth across its digital... ► Artikel lesen |
| Reliance Fined For Incorrect Availment Of Input Tax Credit | MUMBAI (dpa-AFX) - Reliance Industries Limited (500325, RELIANCE) has received an order from the Deputy Commissioner of State Tax, Jamnagar, India imposing on the company a penalty of Rs. 1.11... ► Artikel lesen |
| Research and Markets: Europe Sodium-Ion Battery Analysis Report 2025: Market to Reach $1.49 Billion by 2035 from $50 Million in 2024, Driven by Sustainability, Energy Security, and Reduced Reliance on Imports - ResearchAndMarkets.com | The "Europe Sodium-Ion Battery Market: Focus on Application, Product, and Country Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.
The Europe sodium-ion... ► Artikel lesen |
| Takeda Announces US Availability Of GAMMAGARD LIQUID ERC For Primary Immunodeficiency Treatment | TOKYO (dpa-AFX) - Takeda Pharmaceutical Company Limited (TAK), Thursday announced the U.S. availability of GAMMAGARD LIQUID ERC, which is approved as a replacement therapy for people two years... ► Artikel lesen |
| Halozyme Therapeutics, Inc.: Halozyme Announces Global Collaboration and License Agreement with Takeda to Develop and Commercialize Vedolizumab with ENHANZE | Agreement provides Takeda with exclusive access to ENHANZE® drug delivery technology for vedolizumab
SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Halozyme Therapeutics... ► Artikel lesen |
| Takeda Pharmaceutical, Protagonist Therapeutics Announces Submission Of NDA For Rusfertide | TOKYO (dpa-AFX) - Takeda Pharmaceutical Company Limited (TAK) and Protagonist Therapeutics, Inc. (PTGX), Monday announced the submission of a New Drug Application regarding rusfertide for the... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.